Federal Grant Opportunities
News stories on federal grant opportunities available
Featured Stories
$2 Million Available in Cooperative Agreement for Atopic Dermatitis Clinical Research Centers
by MYRA TUGADE
WASHINGTON, March 19 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a cooperative agreement for Atopic dermatitis research network clinical research centers.
This funding opportunity uses the research project-cooperative agreements mechanism.
The estimated total program funding available was cited as $2 million with a ceiling of $300,000 for each award in the program. The agency said the grant was associated with health.
The funding is open to state, county, city, township and special district governments; independent school
... Show Full Article
WASHINGTON, March 19 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a cooperative agreement for Atopic dermatitis research network clinical research centers.
This funding opportunity uses the research project-cooperative agreements mechanism.
The estimated total program funding available was cited as $2 million with a ceiling of $300,000 for each award in the program. The agency said the grant was associated with health.
The funding is open to state, county, city, township and special district governments; independent schooldistricts; private, public and state controlled institutions of higher education; public housing authorities/Indian housing authorities; Native American tribal governments and organizations; non-profits; non-profits having a 501(c)3 status with the IRS; for profits; and small businesses.
The agency description of the grant states: "The Atopic Dermatitis Research Network Clinical Research Centers (ADRN-CRCs) will conduct the ADRN network-wide clinical research projects under the leadership of the ADRN Leadership Center (ADRN-LC). In parallel, each ADRN-CRC will pursue its own clinical research program in support of the scientific goals of the ADRN. To achieve the ADRN objectives, the ADRN-CRCs will work closely with the ADRN-LC."
The funding opportunity number is RFA-AI-19-015 (CFDA 93.855). It was posted on March 18 with an application closing date of July 8.
$125,000 Funding Available for Promotion of Diversity in Health-Related Research
by MYRA TUGADE
WASHINGTON, March 19 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a discretionary grant for the promotion of diversity in health-related research.
This funding opportunity uses the exploratory/developmental research grant mechanism.
The award ceiling for this funding opportunity is $125,000. The agency said the grant was associated with a) food and nutrition and b) health.
The funding is open to state, county, city, township and special district governments; independent school districts; private, public and state controlled
... Show Full Article
WASHINGTON, March 19 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a discretionary grant for the promotion of diversity in health-related research.
This funding opportunity uses the exploratory/developmental research grant mechanism.
The award ceiling for this funding opportunity is $125,000. The agency said the grant was associated with a) food and nutrition and b) health.
The funding is open to state, county, city, township and special district governments; independent school districts; private, public and state controlledinstitutions of higher education; public housing authorities/Indian housing authorities; Native American tribal governments and organizations; non-profits; non-profits having a 501(c)3 status with the IRS; for profits; and small businesses.
The agency description of the grant states: "The purpose of this Funding Opportunity Announcement (FOA) is to provide support for New Investigators from backgrounds nationally underrepresented in biomedical and behavioral research to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The R21 is intended to support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate the transition to research independence of New Investigators from backgrounds underrepresented in the biomedical and behavioral sciences. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology."
The funding opportunity number is PAR-19-222 (CFDA 93.172, 93.847). It was posted on March 18 with an application closing date of May 7, 2022.
$100,000 Available in Cooperative Agreements for Cultural, Exchange Programming
by MYRA TUGADE
WASHINGTON, March 19 -- The U.S. Department of State announced that it expects to award a cooperative agreement for programs that strengthen cultural ties between the U.S. and Gambia through cultural and exchange programming that highlights shared values and promotes bilateral cooperation.
The estimated total program funding available was cited as $100,000 with a ceiling of $25,000 for each award in the program. The agency said the grant was associated with a) community development, b) education and c) humanities.
The funding is open to private, public and state controlled institutions of higher
... Show Full Article
WASHINGTON, March 19 -- The U.S. Department of State announced that it expects to award a cooperative agreement for programs that strengthen cultural ties between the U.S. and Gambia through cultural and exchange programming that highlights shared values and promotes bilateral cooperation.
The estimated total program funding available was cited as $100,000 with a ceiling of $25,000 for each award in the program. The agency said the grant was associated with a) community development, b) education and c) humanities.
The funding is open to private, public and state controlled institutions of highereducation; non-profits; non-profits having a 501(c)3 status with the IRS; and individuals.
The agency description of the grant states: "The U.S. Embassy Banjul Public Affairs Section (PAS) of the U.S. Department of State is pleased to announce that funding is available through its Public Diplomacy Small Grants Program. All programs must include an American cultural element, or connection with American expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and perspectives.
Examples of PAS Small Grants Program programs include, but are not limited to academic and professional lectures, seminars and speaker programs; artistic and cultural workshops, joint performances and exhibitions; cultural heritage conservation and preservation programs; professional and academic exchanges and programs; academic clubs focusing on extracurricular activities and student achievement; professional training for journalists; and social movement programs to programs to support political transparency.
Priority Program Areas:
1) Strengthening Democratic Institutions
2) Empowering Civil Society
3) Bolstering Education
4) Improving the capacity of Gambians to lead the country's development
All proposals should focus on engaging Gambians in The Gambia. Proposals that reach marginalized communities and youth are encouraged.
The following types of programs are not eligible for funding:
1) Programs relating to partisan political activity;
2) Charitable or development activities;
3) Construction programs;
4) Programs solely focused on purchasing supplies;
5) Programs that support specific religious activities;
6) Fund-raising campaigns;
7) Lobbying for specific legislation or programs;
8) Scientific research;
9) Programs intended primarily for the growth or institutional development of the organization; or
10) Programs that duplicate existing programs."
The funding opportunity number is PAS-BJL-FY19 (CFDA 19.040). It was posted on March 18 with an application closing date of June 15.
$1.6 Million Available in Cooperative Agreements for Research on Autism Spectrum Disorder
by MYRA TUGADE
WASHINGTON, March 19 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to two cooperative agreements for research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Autism spectrum disorder.
The estimated total program funding available was cited as 1.6 million. The agency said the grant was associated with science and technology and other research and development.
The funding is open to state, county, city, township and special district governments; independent school
... Show Full Article
WASHINGTON, March 19 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to two cooperative agreements for research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Autism spectrum disorder.
The estimated total program funding available was cited as 1.6 million. The agency said the grant was associated with science and technology and other research and development.
The funding is open to state, county, city, township and special district governments; independent schooldistricts; private, public and state controlled institutions of higher education; Native American tribal governments and organizations; Historically Black Colleges and Universities; Tribally controlled colleges; non-profits; for profits; small businesses; eligible agencies of the federal government; and faith-based or community-based organizations.
The funding opportunity number is W81XWH-19-ARP-IDA (CFDA 12.420). It was posted on March 18 with an application closing date of Aug. 8.
$1.6 Million Available in Cooperative Agreements for Autism Spectrum Disorder Research
by MYRA TUGADE
WASHINGTON, March 19 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to two cooperative agreements for research to address current clinical deficits for Autism spectrum disorder.
The estimated total program funding available was cited as $1.6 million. The agency said the grant was associated with science and technology and other research and development.
The funding is open to state, county, city, township and special district governments; independent school districts; private, public and state controlled institutions of higher education; Native American
... Show Full Article
WASHINGTON, March 19 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to two cooperative agreements for research to address current clinical deficits for Autism spectrum disorder.
The estimated total program funding available was cited as $1.6 million. The agency said the grant was associated with science and technology and other research and development.
The funding is open to state, county, city, township and special district governments; independent school districts; private, public and state controlled institutions of higher education; Native Americantribal governments and organizations; Historically Black Colleges and Universities; Tribally controlled colleges; non-profits; for profits; small businesses; eligible agencies of the federal government; and faith-based or community-based organizations.
The agency description of the grant states: "If the proposed project does not address any of the FY19 ARP Clinical Translational Research Award Areas of Interest, the application should describe how the project will nevertheless address a critical need of the ASD community. Outcomes from studies funded by this award are anticipated to provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform ASD clinical care. Projects are required to involve human subjects.
Projects that are strictly animal research aimed at developing or refining new technology and research to establish the efficacy/ effectiveness of diagnostic agents are not allowed under this funding opportunity. The proposed studies should include early-phase, proof-of-principle studies using human subjects. The proposed studies may be interventional, including Phase 0 clinical trials or single-group intervention studies, and may involve some retrospective data analysis; however, purely retrospective or database-related research is not allowed."
The funding opportunity number is W81XWH-19-ARP-CTRA (CFDA 12.420). It was posted on March 18 with an application closing date of Aug. 8.
